drugs
Although diuretics remain        the best documented drug class to reduce morbidity and mortality in systemic       hypertension, our data suggest a need for continued vigilance to assess the       risk-benefit ratio of all drugs used for long-term therapy of cardiovascular       disorders.
Although diuretics remain        the best documented drug class to reduce morbidity and mortality in systemic       hypertension, our data suggest a need for continued vigilance to assess the       risk-benefit ratio of all  @SUBJECT$  used for long-term  @PREDICAT$  of  @OBJECT$ .